Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Entecavir-13C2,15N | 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one-13C2,15N; Baraclude-13C2,15N; BMS 200475-13C2,15N; SQ 34676-13C2,15N; | 1329796-53-3 | C10 13C2H15N4 15NO3 | 280.26 | 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one-13C2,15N; Baraclude-13C2,15N; BMS 200475-13C2,15N; SQ 34676-13C2,15N; |
| 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester | C 1609; Carboxyfluorescein Succinimidyl Ester; FLUOS; NHS-Fluorescein; Pierce NHS-Fluorescein; 1-[[[3’,6’-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthen]-5(or 6)-yl]carbonyl]oxy]-2,5-pyrrolidinedione | 117548-22-8 | C25H15NO9 | 473.39 | C 1609; Carboxyfluorescein Succinimidyl Ester; FLUOS; NHS-Fluorescein; Pierce NHS-Fluorescein; 1-[[[3’,6’-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9’-... |
| Entecavir-d2 | 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-(methylidene-d2)cyclopentyl]-3H-purin-6-one; Baraclude-d2; BMS 200475-d2; SQ 34676-d2; | C12H13D2N5O3 | 279.29 | 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-(methylidene-d2)cyclopentyl]-3H-purin-6-one; Baraclude-d2; BMS 200475-d2; SQ 34676-d2; | |
| 5-Carboxy-fluorescein Diacetate N-Succinimidyl Ester | 1-[[[3’,6’-Bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthen]-5-yl]carbonyl]oxy]-2,5-pyrrolidinedione; | 150206-05-6 | C29H19NO11 | 557.46 | 1-[[[3’,6’-Bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthen]-5-yl]carbonyl]oxy]-2,5-pyrrolidinedione;
|
| ent-Entecavir | 2-Amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-Purin-6-one; [1R-(1α,3α,4β)]-2-Amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; | 188399-46-4 | C12H15N5O3 | 277.28 | 2-Amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-Purin-6-one; [1R-(1α,3α,4β)]-2-Amino-1,9-dihydro-9-[4-hydroxy... |
| 21-Carboxylic Acid Triamcinolone Acetonide | (11β,16α)-9-Fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3,20-dioxopregna-1,4-dien-21-oic Acid; | 53962-41-7 | C24H29FO7 | 448.48 | (11β,16α)-9-Fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3,20-dioxopregna-1,4-dien-21-oic Acid;
|
| Entecavir 3’’-O-β-D-Glucuronide | 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one 3’’-O-β-D-Glucuronide; | C18H23N5O9 | 453.4 | 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one 3’’-O-β-D-Glucuronide; | |
| 5’-Acetamido-2’-carboxy-4-dimethylamino-2-hydroxybenzophenone | 4-(Acetylamino)-2-[4-(dimethylamino)-2-hydroxybenzoyl]benzoic Acid; | 166442-37-1 | C18H18N2O5 | 342.35 |
4-(Acetylamino)-2-[4-(dimethylamino)-2-hydroxybenzoyl]benzoic Acid; |
| 21-Carboxylic Acid Fluticasone Dimer Impurity | 21-Carboxylic Acid Fluticasone Dimer Impurity | NA | C42H50F4O9 | 774.83 | 21-Carboxylic Acid Fluticasone Dimer Impurity
|
| Entecavir-13C2,15N 3’’-O-β-D-Glucuronide | 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one-13C2,15N 3’’-O-β-D-Glucuronide; | C17 13C2H24N3 15NO9 | 455.39 | 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one-13C2,15N 3’’-O-β-D-Glucuronide; |
Page 141 of 10017